Predictive Oncology Stock Momentum Indicators MACD with controllable MA type
POAI Stock | USD 0.80 0.05 6.67% |
Symbol |
The output start index for this execution was thirty-three with a total number of output elements of twenty-eight. MACD with controllable MA type is a predictive momentum indicator that shows the relationship between Predictive Oncology price series and its benchmark allowing for selection of moving average.
Predictive Oncology Technical Analysis Modules
Most technical analysis of Predictive Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Predictive from various momentum indicators to cycle indicators. When you analyze Predictive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Predictive Oncology Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Predictive Oncology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Predictive Oncology based on widely used predictive technical indicators. In general, we focus on analyzing Predictive Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Predictive Oncology's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Predictive Oncology's intrinsic value. In addition to deriving basic predictive indicators for Predictive Oncology, we also check how macroeconomic factors affect Predictive Oncology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
2021 | 2022 | 2024 (projected) | Payables Turnover | 0.48 | 0.54 | 0.31 | Days Of Inventory On Hand | 290.55 | 311.08 | 387.01 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Predictive Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Predictive Oncology's short interest history, or implied volatility extrapolated from Predictive Oncology options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Macroaxis Index Invested over 90 shares | ||
Warren Buffett Holdings Invested over 40 shares | ||
Banking Invested over 40 shares | ||
Momentum Invested few shares | ||
Manufacturing Invested over 30 shares | ||
Business Services Invested over 100 shares | ||
Blockchain Invested few shares | ||
Impulse Invested over 100 shares | ||
ESG Investing Invested few shares | ||
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Predictive Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Predictive Oncology. If investors know Predictive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Predictive Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Revenue Per Share 0.416 | Quarterly Revenue Growth (0.43) | Return On Assets (0.56) | Return On Equity (1.49) |
The market value of Predictive Oncology is measured differently than its book value, which is the value of Predictive that is recorded on the company's balance sheet. Investors also form their own opinion of Predictive Oncology's value that differs from its market value or its book value, called intrinsic value, which is Predictive Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Predictive Oncology's market value can be influenced by many factors that don't directly affect Predictive Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Predictive Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Predictive Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Predictive Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.